Boston University Clinical and Translational Science Institute

波士顿大学临床与转化科学研究所

基本信息

批准号：
9261614
负责人：
Darrell N. Kotton
金额：
$ 56.88万
依托单位：
BOSTON UNIVERSITY MEDICAL CAMPUS
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-08-13 至 2019-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9261614
关键词：
Address Adopted Affinity Area Basic Science Biological Biomedical Engineering Biomedical Research Bone Regeneration Boston Cardiology Clinical Clinical Sciences Collaborations Competence Conscious Dentistry Dermatologic Dermatology Development Discipline Doctor of Philosophy Drug Delivery Systems Educational Curriculum Effectiveness Environment Faculty Financial Support Floor Fostering Foundations Framingham Heart Study Funding Future Gastroenterology Geriatrics Goals Hematology Home environment Industry Institutes Institution Intention International Laboratories Leadership Learning Medical Medicine Mentors Mission Molecular Medicine Operative Surgical Procedures Orthopedics Outcome Patients Pediatrics Performance Peripheral Pharmaceutical Preparations Phenotype Play Positioning Attribute Postdoctoral Fellow Process Productivity Program Evaluation Publications Pulmonology Regenerative Medicine Research Research Personnel Research Training Resources Role Science Scientist Section 8 Secure Shapes Sickle Cell Stem Cell Research Stem cells Students Study Subject TNFSF15 gene Teaching Method Technology Time Toxicity Tests Training Training Programs Translational Research Universities Vision Vocational Guidance Workforce Development base bench to bedside career career development cell bank design education research efficacy testing experience foot human disease innovation interdisciplinary approach interest medical schools member mid-career faculty multidisciplinary oncology personalized medicine physical science pre-doctoral programs skills success teacher tool translational medicine translational pipeline

项目摘要

The overarching concepts and goals of the Regenerative Medicine Training Program (RMTP TL1) are to 1) provide an innovative, integrative and interdisciplinary training program for pre- doctoral and post-doctoral trainees which will leverage a unique and internationally recognized strength of BU, 2) establish an environment that facilitates translational team science interactions with trainees, MD scientists and clinicians, thereby synergistically bridging research strengths with interdisciplinary approaches in regenerative medicine, and 3) catapult BU into the forefront of institutions that are producing scientists with the skills and expertise to fulfill a current and future patient-based need for regenerative medicine. The objectives of our training program also align precisely with the general Boston University CTSI (BU CTSI) goals and with the strong emphasis on regenerative medicine at Boston University School of Medicine, as well as to further the mission of NCATS of expediting personalized medicine and the discovery and delivery of drugs to market. The RMTP will provide support for 3 pre-doctoral and 2 post- doctoral trainees each year, totaling 27 pre-doctoral and 18 post-doctoral trainees supported for the duration of the program, with each trainee participating for two years. Accepted trainees will be outstanding students/postdocs and selected based on grades/productivity, quality of the proposal, likely to pursue careers in academic regenerative medicine, highly motivated, energetic, and well-prepared for the curriculum. The curriculum will be competency-based and include rigorous training in didactic and laboratory based concepts and technology. An extensive and individualized mentoring plan will be implemented for each trainee that will included both scientific as well career development guidance. We fully anticipate that under the vision of “todays trainees are the teachers of tomorrow”, the RMTP will generate a continual influx of research and clinical leaders in the stem cell/regenerative medicine field who will make significant contributions resulting in the realization of its full medical potential. We seek to retain a major portion of our trainees, both in our own program and elsewhere, as investigators and mentors in regenerative medicine. Success of the RMTP will be based on the ability to increase the pipeline of well-trained scientists who continue their research in regenerative medicine, the number and quality of their publications, and leadership positions they assume in both industry and academic environments.

再生医学培训计划 (RMTP) 的总体概念和目标 TL1) 旨在 1) 为预科生提供创新、综合和跨学科的培训计划博士和博士后实习生将利用独特且国际认可的 BU 的优势，2) 建立有利于转化团队科学的环境与受训者、医学博士科学家和精神科医生互动，从而协同研究再生医学跨学科方法的优势，以及3）将BU推向培养具有技能和专业知识的科学家的最前沿机构，以实现当前和未来基于患者的再生医学需求。计划也与波士顿大学 CTSI (BU CTSI) 的总体目标完全一致波士顿大学医学院也非常重视再生医学进一步推进 NCATS 的使命，即加快个性化医疗以及发现和 RMTP 将为 3 名博士前和 2 名博士后提供支持。每年资助博士生27名，博士后18名计划的持续时间，每位接受培训的学员将参加两年。是优秀的学生/博士后，并根据成绩/生产力、质量进行选择提案，可能从事学术再生医学职业，积极性高，充满活力，为课程做好充分准备。课程将以能力为基础，包括基于教学和实验室的概念和技术的严格培训。将为每位学员实施广泛且个性化的指导计划我们充分预期这一点包括科学和职业发展指导。 RMTP以“今天的学员是明天的教师”为愿景，将产生持续不断的干细胞/再生医学领域的研究和临床领导者的涌入，他们将使我们寻求保留其充分发挥医疗潜力的重大贡献。我们的大部分学员，无论是在我们自己的项目还是其他地方，作为调查员和 RMTP 的成功将基于提高再生医学领域导师的能力。训练有素的科学家继续在再生医学领域进行研究，他们出版物的数量和质量，以及他们在两个行业中担任的领导地位和学术环境。